Discover a Treatment That Could Help You Move Forward with Less Pain
Still struggling with joint stiffness, skin discomfort, or chronic fatigue caused by arthritis or plaque psoriasis?
RINVOQ (upadacitinib) is an FDA-approved prescription medication designed to help adults manage moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), and moderate to severe plaque psoriasis (PsO)—especially for those who have had an inadequate response to previous treatments.
Why Are More Patients Turning to RINVOQ?
Taken orally once daily—no injections required
Clinically proven to reduce joint pain, swelling, and stiffness
Can help improve mobility and skin clarity in just a few weeks for some patients*
Approved for multiple chronic inflammatory conditions
*Results may vary from person to person
Real Stories from People Using RINVOQ*
"I was struggling with everyday tasks—now I can hold a pen and open jars again."
— Linda R., age 56, Georgia
"Not having to take injections is a big relief. I started noticing improvements within weeks."
— Mark T., age 45, Ohio
*Individual experiences do not reflect typical outcomes. Always talk to your doctor before starting a new treatment.
Who Makes RINVOQ?
RINVOQ is developed and manufactured by AbbVie, a U.S.-based global biopharmaceutical company committed to addressing serious health challenges.
With decades of experience in immunology, AbbVie is known for advancing therapies in areas like rheumatology, dermatology, oncology, and neurology.
AbbVie also offers comprehensive patient assistance programs to help eligible patients access treatment at lower out-of-pocket costs.
How to Access RINVOQ at Lower Cost—or Explore Assistance Options
RINVOQ Complete Support Program
Eligible patients with commercial insurance may pay as little as $5 per month¹
Insurance navigation, reimbursement support, and nurse ambassadors available
Personalized medication support and refill coordination
To check your eligibility or apply:
Visit [www.RINVOQ.com] or call 1-800-RINVOQ-4U
AbbVie Patient Assistance Foundation (PAF)
For patients without insurance or with limited income, AbbVie’s nonprofit foundation may offer free access to RINVOQ.
Applications must be completed by a licensed healthcare provider, and eligibility is determined based on income and medical need.
Additional Resources
Some nonprofit clinics, patient advocacy groups, and local assistance programs may also help coordinate access to AbbVie medications.
Terms and conditions apply. Actual cost may vary depending on your insurance plan.
What Should You Do Next?
Talk with your rheumatologist or dermatologist to see if RINVOQ is right for your condition
Review the full Prescribing Information, including potential side effects and risk factors
Use AbbVie’s support services to explore cost-saving options and get personalized guidance
Don’t Let Chronic Conditions Define Your Daily Life
RINVOQ may be the next step toward relief and greater mobility.
Learn if it's the right option for you and explore available patient support resources.
Important Safety Information
RINVOQ may increase the risk of serious infections, heart attack, stroke, certain cancers, blood clots, and allergic reactions.
Do not take RINVOQ if you are pregnant, planning to become pregnant, or breastfeeding. Regular blood testing is recommended during treatment. Always consult a licensed healthcare provider before starting or changing any medication.